
Intersect ENT, Inc. Retained Earnings 2011-2026 | XENT
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Intersect ENT, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -303 M | -231 M | -188 M | -165 M | -148 M | -123 M | -96.6 M | -78.3 M | -59.9 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -59.9 M | -303 M | -155 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
2.48 B | $ 173.14 | -0.8 % | $ 13 B | ||
|
Bio-Rad Laboratories
BIO
|
7.42 B | $ 279.25 | 0.63 % | $ 7.88 B | ||
|
Alphatec Holdings
ATEC
|
-1.42 B | $ 10.9 | -1.54 % | $ 1.64 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-633 M | $ 12.17 | -0.41 % | $ 1.64 B | ||
|
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | ||
|
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.61 | 0.84 % | $ 38 M | ||
|
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | ||
|
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.3 | -1.79 % | $ 124 M | ||
|
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
2.41 B | $ 37.59 | -1.03 % | $ 5.6 K | ||
|
Boston Scientific Corporation
BSX
|
5.57 B | $ 61.79 | 0.83 % | $ 91.5 B | ||
|
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | ||
|
Helius Medical Technologies
HSDT
|
-160 M | $ 1.89 | - | $ 1.15 M | ||
|
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | ||
|
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.0 | -3.86 % | $ 16.9 M | ||
|
ClearPoint Neuro
CLPT
|
-217 M | $ 8.68 | -3.12 % | $ 246 M | ||
|
Electromed
ELMD
|
21.2 M | $ 24.12 | -1.19 % | $ 204 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.97 | 0.19 % | $ 375 M | ||
|
Inogen
INGN
|
-176 M | $ 6.33 | -4.95 % | $ 168 M | ||
|
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | ||
|
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | ||
|
LivaNova PLC
LIVN
|
-1.15 B | $ 62.78 | -0.93 % | $ 3.42 B | ||
|
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | ||
|
LENSAR
LNSR
|
-178 M | $ 5.7 | 4.4 % | $ 68.2 M | ||
|
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-395 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
1.39 B | $ 90.42 | -1.07 % | $ 12.2 B | ||
|
Butterfly Network
BFLY
|
-802 M | $ 4.11 | -0.96 % | $ 870 M | ||
|
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-529 M | $ 10.04 | 1.62 % | $ 360 M | ||
|
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | ||
|
Myomo
MYO
|
-119 M | $ 0.69 | -1.43 % | $ 28.9 M | ||
|
Inspire Medical Systems
INSP
|
-146 M | $ 54.02 | -4.71 % | $ 1.59 B | ||
|
CONMED Corporation
CNMD
|
589 M | $ 36.74 | -0.51 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
994 M | $ 85.11 | -1.8 % | $ 2.96 B | ||
|
FONAR Corporation
FONR
|
-33.6 M | $ 18.68 | 0.38 % | $ 122 M | ||
|
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 77.87 | -1.62 % | $ 45.5 B |